Hutch News

Hutch News

Stories tagged 'advanced melanoma'

Investigational immunotherapy halts advanced melanoma

Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer

March 5, 2012 | By Dean Forbes

A small, early-phase clinical trial, led by Dr. Cassian Yee of the Hutchinson Center's Clinical Research Division, to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown that the approach has promise. One patient of the 11 experienced a long-term, complete remission that has lasted more than three years, and in four others with progressive disease, the melanoma temporarily stopped growing. The results of the study appear in the March 5 early edition of the Proceedings of the National Academy of Sciences.

View story >

$10 million bolster for immunotherapy research

Challenge gift will fund research that harnesses the immune system to fight cancer

Nov. 23, 2009 | By Kristen Woodward

The Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.